vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and NATURES SUNSHINE PRODUCTS INC (NATR). Click either name above to swap in a different company.
BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $123.8M, roughly 1.5× NATURES SUNSHINE PRODUCTS INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs 2.7%, a 0.6% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs 4.7%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $7.6M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs 5.6%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
BL vs NATR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $123.8M |
| Net Profit | $4.9M | $4.1M |
| Gross Margin | 75.2% | 72.5% |
| Operating Margin | 3.7% | 4.3% |
| Net Margin | 2.7% | 3.3% |
| Revenue YoY | 8.1% | 4.7% |
| Net Profit YoY | -91.3% | 1379.4% |
| EPS (diluted) | $0.07 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $123.8M | ||
| Q3 25 | $178.3M | $128.3M | ||
| Q2 25 | $172.0M | $114.8M | ||
| Q1 25 | $166.9M | $113.2M | ||
| Q4 24 | $169.5M | $118.2M | ||
| Q3 24 | $165.9M | $114.6M | ||
| Q2 24 | $160.5M | $110.6M | ||
| Q1 24 | $157.5M | $111.0M |
| Q4 25 | $4.9M | $4.1M | ||
| Q3 25 | $5.3M | $5.3M | ||
| Q2 25 | $8.3M | $5.3M | ||
| Q1 25 | $6.1M | $4.7M | ||
| Q4 24 | $56.4M | $-321.0K | ||
| Q3 24 | $17.2M | $4.3M | ||
| Q2 24 | $76.7M | $1.3M | ||
| Q1 24 | $10.8M | $2.3M |
| Q4 25 | 75.2% | 72.5% | ||
| Q3 25 | 75.1% | 73.3% | ||
| Q2 25 | 75.2% | 71.7% | ||
| Q1 25 | 75.5% | 72.1% | ||
| Q4 24 | 75.6% | 72.0% | ||
| Q3 24 | 75.2% | 71.3% | ||
| Q2 24 | 74.9% | 71.4% | ||
| Q1 24 | 75.2% | 71.2% |
| Q4 25 | 3.7% | 4.3% | ||
| Q3 25 | 4.3% | 7.0% | ||
| Q2 25 | 4.4% | 3.7% | ||
| Q1 25 | 2.1% | 5.4% | ||
| Q4 24 | 3.7% | 3.8% | ||
| Q3 24 | 5.0% | 4.6% | ||
| Q2 24 | 1.4% | 5.1% | ||
| Q1 24 | 1.1% | 4.2% |
| Q4 25 | 2.7% | 3.3% | ||
| Q3 25 | 3.0% | 4.2% | ||
| Q2 25 | 4.8% | 4.6% | ||
| Q1 25 | 3.6% | 4.2% | ||
| Q4 24 | 33.3% | -0.3% | ||
| Q3 24 | 10.4% | 3.8% | ||
| Q2 24 | 47.8% | 1.2% | ||
| Q1 24 | 6.9% | 2.1% |
| Q4 25 | $0.07 | $0.23 | ||
| Q3 25 | $0.09 | $0.30 | ||
| Q2 25 | $0.13 | $0.28 | ||
| Q1 25 | $0.10 | $0.25 | ||
| Q4 24 | $0.79 | $-0.02 | ||
| Q3 24 | $0.27 | $0.23 | ||
| Q2 24 | $0.22 | $0.07 | ||
| Q1 24 | $0.17 | $0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $93.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $161.6M |
| Total Assets | $1.8B | $261.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $93.9M | ||
| Q3 25 | $419.9M | $95.6M | ||
| Q2 25 | $459.1M | $81.3M | ||
| Q1 25 | $479.5M | $86.5M | ||
| Q4 24 | $885.9M | $84.7M | ||
| Q3 24 | $725.3M | $78.7M | ||
| Q2 24 | $616.6M | $68.7M | ||
| Q1 24 | $331.4M | $77.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $2.1M |
| Q4 25 | $332.3M | $161.6M | ||
| Q3 25 | $328.3M | $166.7M | ||
| Q2 25 | $414.0M | $163.7M | ||
| Q1 25 | $417.9M | $167.1M | ||
| Q4 24 | $446.7M | $161.0M | ||
| Q3 24 | $367.9M | $162.6M | ||
| Q2 24 | $325.8M | $156.4M | ||
| Q1 24 | $279.8M | $159.7M |
| Q4 25 | $1.8B | $261.1M | ||
| Q3 25 | $1.7B | $264.8M | ||
| Q2 25 | $1.8B | $254.9M | ||
| Q1 25 | $1.8B | $252.7M | ||
| Q4 24 | $1.8B | $240.9M | ||
| Q3 24 | $1.7B | $245.3M | ||
| Q2 24 | $1.9B | $235.8M | ||
| Q1 24 | $2.1B | $247.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.01× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $9.9M |
| Free Cash FlowOCF − Capex | $26.1M | $7.6M |
| FCF MarginFCF / Revenue | 14.2% | 6.1% |
| Capex IntensityCapex / Revenue | 0.3% | 1.9% |
| Cash ConversionOCF / Net Profit | 5.46× | 2.41× |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $28.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $9.9M | ||
| Q3 25 | $63.8M | $18.5M | ||
| Q2 25 | $32.3M | $4.3M | ||
| Q1 25 | $46.7M | $2.6M | ||
| Q4 24 | $43.8M | $12.2M | ||
| Q3 24 | $55.9M | $9.6M | ||
| Q2 24 | $40.7M | $1.3M | ||
| Q1 24 | $50.4M | $2.2M |
| Q4 25 | $26.1M | $7.6M | ||
| Q3 25 | $63.3M | $16.8M | ||
| Q2 25 | $31.4M | $3.0M | ||
| Q1 25 | $40.8M | $1.5M | ||
| Q4 24 | $43.0M | $10.0M | ||
| Q3 24 | $55.5M | $7.9M | ||
| Q2 24 | $40.0M | $-2.0M | ||
| Q1 24 | $50.1M | $-1.5M |
| Q4 25 | 14.2% | 6.1% | ||
| Q3 25 | 35.5% | 13.1% | ||
| Q2 25 | 18.2% | 2.6% | ||
| Q1 25 | 24.4% | 1.3% | ||
| Q4 24 | 25.4% | 8.5% | ||
| Q3 24 | 33.5% | 6.9% | ||
| Q2 24 | 24.9% | -1.9% | ||
| Q1 24 | 31.8% | -1.4% |
| Q4 25 | 0.3% | 1.9% | ||
| Q3 25 | 0.3% | 1.3% | ||
| Q2 25 | 0.6% | 1.2% | ||
| Q1 25 | 3.6% | 1.0% | ||
| Q4 24 | 0.4% | 1.9% | ||
| Q3 24 | 0.2% | 1.5% | ||
| Q2 24 | 0.4% | 3.0% | ||
| Q1 24 | 0.2% | 3.3% |
| Q4 25 | 5.46× | 2.41× | ||
| Q3 25 | 12.07× | 3.46× | ||
| Q2 25 | 3.90× | 0.81× | ||
| Q1 25 | 7.72× | 0.55× | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 3.24× | 2.21× | ||
| Q2 24 | 0.53× | 0.97× | ||
| Q1 24 | 4.66× | 0.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
